Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Zinbryta vs. Ocrevus

Are Zinbryta and Ocrevus the Same Thing?

Zinbryta (daclizumab) injection and Ocrevus (ocrelizumab) injection are monoclonal antibodies used to treat patients with relapsing forms of multiple sclerosis (MS).

Because of its safety profile, the use of Zinbryta should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.

Ocrevus is also used to treat primary progressive forms of multiple sclerosis.

Zinbryta and Ocrevus are different types of monoclonal antibodies. Zinbryta is an interleukin-2 receptor blocking antibody and Ocrevus injection is aCD20-directed cytolytic antibody.

Side effects of Zinbryta and Ocrevus that are similar include upper respiratory tract infection, lower respiratory tract infections (such as bronchitis), and depression.

Side effects of Zinbryta that are different from Ocrevus include runny or stuffy nose, skin rash (including drug rash), influenza, mouth pain, sore throat, eczema, swollen lymph nodes, increased alanine aminotransferase (ALT), anemia, acne, and fever.

Side effects of Ocrevus that are different from Zinbryta include infusion reactions (itching, rash, hives, redness, bronchospasm, swollen and sore throat, mouth pain, shortness of breath, flushing, hypotension, fever, fatigue, headache, dizziness, nausea, and fast heart rate), skin infections, back pain, and pain in the extremities.

Zinbryta may interact with drugs or herbal products that are toxic to the liver.

Ocrevus may interact with other immune-modulating or immunosuppressive therapies, including immunosuppressant doses of corticosteroids.

What Are Possible Side Effects of Zinbryta?

Common side effects of Zinbryta include:

  • runny or stuffy nose
  • upper respiratory tract infection
  • rash, including drug rash
  • influenza
  • skin rash
  • mouth pain
  • sore throat
  • bronchitis
  • eczema
  • swollen lymph nodes
  • depression
  • increased alanine aminotransferase (ALT)
  • acne
  • anemia, and
  • fever

Less common side effects of Zinbryta include:

What Are Possible Side Effects of Ocrevus?

Common side effects of Ocrevus include:

  • upper respiratory tract infections,
  • infusion reactions (itching, rash, hives, redness, bronchospasm, swollen and sore throat, mouth pain, shortness of breath, flushing, hypotension, fever, fatigue, headache, dizziness, nausea, and fast heart rate),
  • skin infections,
  • lower respiratory tract infections,
  • depression,
  • back pain, and
  • pain in the extremities.

What Is Zinbryta?

Zinbryta (daclizumab) injection is an interleukin-2 receptor blocking antibody indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Zinbryta should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.

What Is Ocrevus?

Ocrevus (ocrelizumab) injection is aCD20-directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis.

QUESTION

What kind of disease is multiple sclerosis? See Answer

What Drugs Interact With Zinbryta?

Zinbryta may interact with hepatotoxic drugs or herbal products. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant before taking Zinbryta. It is unknown if it would affect a fetus. It is unknown if Zinbryta passes into breast milk or if it would affect a nursing infant. Consult your doctor before breastfeeding.

What Drugs Interact With Ocrevus?

Hepatitis B virus screening is required before the first dose of Ocrevus. Pre-medicate with methylprednisolone (or an equivalent corticosteroid) and an antihistamine prior to each infusion. The starting dose of Ocrevus is 300 mg intravenous infusion, followed two weeks later by a second 300 mg intravenous infusion. Subsequent doses of Ocrevus are 600 mg intravenous infusion every 6 months.

How Should Zinbryta Be Taken?

The recommended dosage of Zinbryta is 150 milligrams once monthly.

How Should Ocrevus Be Taken?

The recommended dosage of Ocrevus is 12 mg/day administered by intravenous infusion for 2 treatment courses: First Treatment Course: 12 mg/day on 5 consecutive days (60 mg total dose; Second Treatment Course: 12 mg/day on 3 consecutive days (36 mg total dose) administered 12 months after the first treatment course.

SLIDESHOW

What Is Multiple Sclerosis? MS Symptoms, Causes, Diagnosis See Slideshow
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

Reviewed on 10/17/2019
References
Biogen. Zinbryta Product Information

https://www.biogenoptions.com/?cid=aff-zinbryta-zinbryta_com-hp

Genentech. Ocrevus Product Information

www.ocrevus.com/?
CONTINUE SCROLLING FOR RELATED SLIDESHOW

Health Solutions From Our Sponsors